TriSalus Life Sciences (TLSIW) EBT Margin (2022 - 2026)
TriSalus Life Sciences (TLSIW) reported EBT Margin of 17.34% for Q1 2026, up 13046.0% on a YoY basis from N/an in Q1 2025, and up 123.48% quarter-over-quarter from 73.86% in Q4 2025.
TriSalus Life Sciences (TLSIW) EBT Margin (2022 - 2026) Analysis & Trends
TriSalus Life Sciences has reported EBT Margin for 5 years, with the latest figure at 17.34% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin rose 13046.0% year-over-year to 17.34%; the trailing twelve-month figure through Mar 2026 stood at 60.84% (up 2381.0% YoY), and the FY2025 full-year result was 86.86%, up 1520.0% from the prior year.
- EBT Margin for Q1 2026 stood at 17.34%, up from 73.86% in the prior quarter.
- The five-year high for EBT Margin was 17.34% in Q1 2026, with the low at 698.57% in Q4 2022.
- Historically, EBT Margin has averaged 192.7% across 5 years, with a median of 113.12% in 2025.
- Annual changes were most pronounced in 2024 — EBT Margin soared 50056 bps — and 2025, when it plunged 6074 bps.
- TriSalus Life Sciences' EBT Margin stood at 698.57% in 2022, then rose by 11 bps to 622.93% in 2023, then surged by 80 bps to 122.37% in 2024, then jumped by 40 bps to 73.86% in 2025, then soared by 123 bps to 17.34% in 2026.
- The last three EBT Margin figures came in at 17.34% (Q1 2026), 73.86% (Q4 2025), and 93.43% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 15.57% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 27.84% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 4.87% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 22.61% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 9.84% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 19.17% |
| 10 | TriSalus Life Sciences | - | - | 7.67 Mn | 17.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.34% |
| Dec 31, 2025 | -73.86% |
| Sep 30, 2025 | -93.43% |
| Jun 30, 2025 | -73.94% |
| Mar 31, 2025 | -113.12% |
| Dec 31, 2024 | -122.37% |
| Sep 30, 2024 | -32.68% |
| Jun 30, 2024 | -58.73% |
| Mar 31, 2024 | -204.48% |
| Dec 31, 2023 | -622.93% |
| Sep 30, 2023 | -27.44% |
| Jun 30, 2023 | -302.71% |
| Mar 31, 2023 | -277.25% |
| Dec 31, 2022 | -698.57% |
| Sep 30, 2022 | -206.30% |